Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEEDS: nCRT vs dCRT in Esophageal SCC
NCT04460352Phase 3Recruiting
- Sponsor
- Karolinska University Hospital
- Start
- Nov 2020
- Primary completion
- Dec 2026
- Countries
- 5
01
Overview
Phase 3, randomised, open-label trial in Esophageal Squamous Cell Carcinoma (ESCC) (2 arms), sponsored by Karolinska University Hospital. Primary endpoints: Overall Survival at 3 years, Global Health-related Quality of Life at 1 year and 1 more. Started Nov 2020; status: recruiting.
02
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT04460352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04460352.